530 results on '"Fattovich, Giovanna"'
Search Results
2. An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C
3. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy
4. Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin
5. The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes
6. Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome
7. Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis
8. Core Protein Evolution After Selection of Hepatitis B Precore Mutants and Correlation with Disease Severity
9. Hepatitis C Virus Infection and Replication in Patients with Hepatocellular Carcinoma
10. Intracellular Distribution of Hepatitis B Virus Core Protein Expressed in Vitro Depends on the Sequence of the Isolate and the Serologic Pattern
11. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study
12. Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients
13. Reduced serum hepcidin levels in patients with chronic hepatitis C
14. Toll Like Receptor 4 D299G Associates with Disease Progression in Caucasian Patients with Chronic HBV Infection: Relationship with Gender
15. Mutations and Deletions within the Hepatitis B Virus Core Antigen and Locations of B Cell Recognition Sites (with Reply)
16. Hepatitis B Virus Core Protein Mutations Are Concentrated in B Cell Epitopes in Progressive Disease and in T Helper Cell Epitopes during Clinical Remission
17. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
18. Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters
19. Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B
20. Clinical efficacy of highly effective interferon-free therapy in patients with chronic HCV infection and compensated advanced hepatic fibrosis: 76
21. Cryoglobulinemia Related to Hepatitis C Virus Infection
22. Natural history of chronic hepatitis B
23. Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy
24. Effects of interferon plus ribavirin treatment on NF-κB, TGF-β1, and metalloproteinase activity in chronic hepatitis C
25. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
26. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C
27. TLR4 rs4986790 A>G genetic polymorphisms predict liver fibrosis severity in caucasian patients with chronic hepatitis B: 1863
28. TLR4 rs4986790 A>G genetic polymorphisms predicts liver fibrosis severity in caucasian patients with chronic hepatitis C: 1033
29. The evolving clinical profile of chronic HBV infection. The Italian Master-B cohort: 923
30. Progression to cirrhosis and mortality of chronic hepatitis type b: a cohort study with 25 years follow-up in Italy: 319
31. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C
32. The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients
33. A Seven-Gene Signature (Cirrhosis Risk Score) Predicts Liver Fibrosis Progression in Patients with Initially Mild Chronic Hepatitis C†
34. Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C
35. 12 Hepatitis C and cirrhosis
36. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
37. Natural History and Prognosis of Hepatitis B
38. A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C
39. Natural history of hepatitis B
40. Influence of GB virus-C/hepatitis G virus infection on the long-term course of chronic hepatitis B
41. Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B
42. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients
43. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C
44. Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis
45. Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy
46. A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon
47. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis: a prospective study
48. Changes in Serum Hepatitis B Virus (HBV) DNA Positivity in Chronic HBV Infection: Results of a Long-Term Follow-Up Study of 138 Patients
49. Influence of Hepatitis Delta Virus Infection on Progression to Cirrhosis in Chronic Hepatitis Type B
50. Hepatitis C Virus Infection in Chronic Hepatitis B Virus Carriers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.